Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent HPV vaccine efficacy study in young men
2004-002945-10Phase 3Completed
- Sponsor
- MSD
- Start
- Nov 2004
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quadrivalent human papillomavirus vaccine in human papillomavirus infection and anogenital warts (2 arms), sponsored by MSD. Primary endpoint: HPV 6-, 11-, 16-, and 18-related anogenital warts. Started Nov 2004; status: completed.
02
Drugs
quadrivalent human papillomavirus vaccine
03
Conditions
human papillomavirus infectionanogenital warts
Beyond the preview
Go deeper on 2004-002945-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002945-10.